晚期第三个跨导管大动脉替换用于治疗持久的准膜吐
Valentina Frittitta1, Giuliano Costa1, Maria Teresa Cannizzaro2
1Division of Cardiology, AOU Policlinico G. Rodolico-San Marco, Catania, Italy.
JACC. Case reports
|April 22, 2024
概括
过导管大动脉置换 (TAVR) 后严重的准膜反可能导致不良结果. 这一案例突出了第三次成功的TAVR严重吐,强调了程序前规划.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 准膜反 (PVR) 是通过导管的大动脉置换 (TAVR) 后的一个常见并发症.
- 超过轻度的PVR与不良的临床结果有关.
- 重复TAVR程序越来越多地用于管理严重PVR等并发症.
相关概念视频
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
170
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
170
01:27Pneumothorax-II
141
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
141